{"id":726,"date":"2015-07-06T09:46:42","date_gmt":"2015-07-06T13:46:42","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=726"},"modified":"2015-07-06T10:22:10","modified_gmt":"2015-07-06T14:22:10","slug":"june-2015-ipo-track-record-recap","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/june-2015-ipo-track-record-recap\/","title":{"rendered":"June 2015 IPO Track Record Recap"},"content":{"rendered":"<p>It was a second straight month with a strong number of IPOs that came to market as the month of June saw a total of 27 deals price&#8211;the most in a single month thus far in 2015. While that number is large and indeed <a href=\"http:\/\/www.cnbc.com\/id\/101519560\" target=\"_blank\">caused angst among investors and media-talking-heads <\/a>alike, it is not entirely strange to see a high quantity of deals debut in the month of June. In June 2014, 28 deals debuted and in June 2013, a total of 18 new public offerings hit the market.<\/p>\n<p>The 2015 IPO numbers as a whole still pale in comparison to 2014. There have been a total of 91 deals that have priced thus far in 2015 as compared to 136 at this same point a year ago.<\/p>\n<p>This post will allow us to post our results and emphasize the value of IPOBoutique&#8217;s senior managing partner Scott Sweet&#8217;s ratings. You can check out <strong>o<a href=\"https:\/\/www.ipoboutique.com\/cgi\/ipo-track-record-summary-report.php\" target=\"_blank\">ur entire track record at this link.\u00a0<\/a><\/strong><\/p>\n<p>Here is a recap of our past performances:<\/p>\n<ul>\n<li><strong><a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=226\" target=\"_blank\">January 2015<\/a><\/strong><\/li>\n<li><strong><a title=\"February 2015 IPO Track Record Recap\" href=\"http:\/\/www.ipoboutique.com\/blog\/february-2015-ipo-recap\/\">February 2015<\/a><\/strong><\/li>\n<li><a title=\"March 2015 IPO Track Record Recap\" href=\"http:\/\/www.ipoboutique.com\/blog\/march-2015-ipo-track-record-recap\/\"><strong>March 2015<\/strong><\/a><\/li>\n<li><a title=\"April 2015 IPO Track Record Recap\" href=\"http:\/\/www.ipoboutique.com\/blog\/april-2015-ipo-track-record-recap\/\"><strong>April 2015<\/strong><\/a><\/li>\n<li><strong><a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=635\" target=\"_blank\">May 2015<\/a><\/strong><!--more--><\/li>\n<\/ul>\n<p><strong><span style=\"text-decoration: underline;\">Five-Rating<\/span><\/strong><\/p>\n<p>We consider these IPOs to be the best of the best. In our nine years of keeping a track-record we have given just 14 \u2018five-ratings\u2019 and all 14 have hit their respective targets. However, in June 2015, we did not give a \u2018five\u2019 rating.<\/p>\n<p><strong><span style=\"text-decoration: underline;\">Four-Rating<\/span><\/strong><\/p>\n<p>We consider these IPOs to be very strong buys and we anticipate 1-to-2 points of premium above the offering price <strong>at first trade.<\/strong> In June 2015, we dished out a total of eight, &#8216;four-ratings&#8217;. Three IPOs delivered double-digit premiums upon opening&#8211;<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Wingstop-WING\" target=\"_blank\"><strong>Wingstop (Nasdaq: WING)<\/strong><\/a>, <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Fitbit-FIT\" target=\"_blank\"><strong>FitBit (NYSE: FIT)<\/strong><\/a> &amp; <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/GlaukosCorporation-GKOS\" target=\"_blank\"><strong>Glaukos Corporation (NYSE: GKOS)<\/strong><\/a>.\u00a0 <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/DavidsTea-DTEA\" target=\"_blank\"><strong>DAVIDsTea (Nasdaq: DTEA)<\/strong><\/a> and <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/FogoDeChao-FOGO\" target=\"_blank\"><strong>Fogo De Chao (Nasdaq: FOGO)<\/strong> <\/a>debuted with first trades of $6.01 and $6.00 above the offering price, respectively.\u00a0 Other four rated deals this past month were <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Transunion-TRU\" target=\"_blank\"><strong>TransUnion (NYSE: TRU)<\/strong><\/a>, <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/EvolentHealth-EVH\" target=\"_blank\"><strong>Evolent Health (NYSE: EVH)<\/strong> <\/a>and <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AlarmHoldings-ALRM\" target=\"_blank\"><strong>Alarm.Com (Nasdaq: ALRM)<\/strong><\/a>.\u00a0 In June 2015, the average return of our &#8216;four-rated&#8217; deals was <strong>$6.27<\/strong>.\u00a0 To this point in 2015 we have rated a total of 20 deals with a &#8216;four-rating&#8217; and the average opening above the offering price is $8.53. In 2014, we rated 42 IPOs with a \u2018four\u2019 rating and these deals produced an average of $8.73 above the IPO price at first trade. Additionally, this month marks the 24th consecutive month of &#8216;four-rated&#8217; deals hitting its designated mark of, at minimum, a one-point premium above the offering price.<\/p>\n<p><strong><span style=\"text-decoration: underline;\">Three-Rating<\/span><\/strong><\/p>\n<p>We consider these IPOs to be moderate buys and we anticipate 1\/2 to 1 point premium or more likely in the cases of these new issues. This past month 11 deals debuted that we rated as a &#8216;three&#8217;&#8230;with an average <strong>rate of return of $2.22 <\/strong>above the offering price at first trade. The best of the bunch was<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/SeresTherapeutics-MCRB\" target=\"_blank\"><strong> Seres Therapeutics (Nasdaq: MCRB)<\/strong><\/a> which opened $10.50 above the $18.00 offering price. <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AxovantSciences-AXON\" target=\"_blank\"><strong>Axovant Sciences (Nasdaq: AXON)<\/strong><\/a> also debuted nicely with a $5.93 premium above the $15.00 offering price. Nine of our eleven &#8216;3&#8217; rated deals hit their designated target of at least a $0.50 premium above the offering price. Our rate of success in hitting our target for &#8216;3&#8217; rated deals is at 88% for the 2015 calendar year. There have now been 40 IPOs that IPOBoutique has rated as a &#8216;3&#8217; this year with the <strong>average return above the offering price at first trade being $2.42<\/strong>.\u00a0 In 2014, we rated 95 IPOs that came to market with a \u2018three\u2019 rating and the average gain above the IPO price at first trade was $1.95.<\/p>\n<p><strong><span style=\"text-decoration: underline;\">Two-Rating<\/span><\/strong><\/p>\n<p>We consider these IPOs to be \u201cneutral\u201d and thus do not have a particular point threshold to hit in order for us to deem it as \u2018hitting its target\u2019. We gave eight deals a &#8216;two-rating&#8217; and <span style=\"color: #ff0000;\">four of the eight deals either opened flat or below<\/span> the offering price.\u00a0 The average first trade came <span style=\"color: #000000;\">$0.06 above the offering price<\/span>. So far in 2015, IPO Boutique has rated a total of 38 deals with a &#8216;two&#8217; rating and those deals have returned an average <span style=\"color: #000000;\">of <span style=\"color: #ff0000;\">$0.03 below the offering price<\/span> a<\/span>t first trade. In 2014, we rated a total of <strong>124 deals\u00a0<\/strong>a &#8216;two-rating&#8217; and the average gain above the IPO price at first trade for the 124 deals was $0.36.<\/p>\n<p><strong><span style=\"text-decoration: underline;\">One-Rating<\/span><\/strong><\/p>\n<p>We advise our subscribers to avoid these IPOs as we consider them to be risky. In our nine years of keeping a track-record we have given just 49 \u2018one\u2019 ratings. In June, we did not give a \u2018one\u2019 rating.<\/p>\n<p>IPOBoutique.Com provides comprehensive research, ratings and daily advisories on new issues hitting the IPO market. To subscribe to IPOBoutique&#8217;s service: <a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">click here. <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>It was a second straight month with a strong number of IPOs that came to market as the month of June saw a total of 27 deals price&#8211;the most in a single month thus far in 2015. While that number is large and indeed caused angst among investors and media-talking-heads alike, it is not entirely[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,165],"tags":[491,456,449,452,441,475,496,499,501,453],"class_list":["post-726","post","type-post","status-publish","format-standard","hentry","category-ipo","category-monthly-recap","tag-alrm","tag-axon","tag-dtea","tag-evh","tag-fit","tag-fogo","tag-gkos","tag-mcrb","tag-tru","tag-wing"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=726"}],"version-history":[{"count":6,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/726\/revisions"}],"predecessor-version":[{"id":735,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/726\/revisions\/735"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}